We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

J&J Found Liable In 3rd Risperdal Breast-Growth Case

Law360, Philadelphia (December 11, 2015, 4:14 PM EST) -- A Philadelphia jury returned a $500,000 verdict against a Johnson & Johnson unit on Friday after agreeing that the antipsychotic drug Risperdal caused a Wisconsin boy to grow female breasts and...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.